US Stock MarketDetailed Quotes

TLX Telix Pharmaceuticals

Watchlist
  • 14.700
  • -0.068-0.46%
Close Nov 22 16:00 ET
  • 14.700
  • 0.0000.00%
Post 16:00 ET
5.17BMarket Cap161.54P/E (TTM)

Telix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
(FY)Dec 30, 2020
(FY)Dec 30, 2019
Total revenue
218.40%496.66M
3,084.65%155.98M
4.66%4.9M
34.29%4.68M
3.49M
Operating revenue
218.40%496.66M
3,084.65%155.98M
4.66%4.9M
34.29%4.68M
--3.49M
Cost of revenue
205.67%188.16M
2,315.86%61.56M
25.89%2.55M
-20.41%2.02M
2.54M
Gross profit
226.71%308.5M
3,918.21%94.43M
-11.52%2.35M
181.95%2.66M
942K
Operating expense
42.13%269.27M
87.29%189.44M
92.88%101.15M
27.29%52.44M
41.2M
Selling and administrative expenses
43.15%133.85M
129.12%93.5M
112.46%40.81M
65.77%19.21M
--11.59M
-Selling and marketing expense
238.96%54.87M
174.78%16.19M
390.10%5.89M
285.26%1.2M
--312K
-General and administrative expense
2.16%78.99M
121.42%77.32M
93.93%34.92M
59.70%18.01M
--11.28M
Research and development costs
122.69%128.84M
69.49%57.86M
47.87%34.14M
9.09%23.09M
--21.16M
Depreciation amortization depletion
25.36%6.74M
3.96%5.38M
5.98%5.17M
15.25%4.88M
--4.24M
-Depreciation and amortization
25.36%6.74M
3.96%5.38M
5.98%5.17M
15.25%4.88M
--4.24M
Other operating expenses
-100.53%-173K
55.50%32.7M
299.30%21.03M
25.02%5.27M
--4.21M
Operating profit
141.29%39.24M
3.83%-95.02M
-98.45%-98.8M
-23.67%-49.79M
-40.26M
Net non-operating interest income expense
-90.57%-12.75M
-28.25%-6.69M
-370.94%-5.22M
52.03%-1.11M
-2.31M
Non-operating interest income
101,800.00%1.02M
--1K
----
-31.63%67K
--98K
Non-operating interest expense
104.74%13.14M
22.96%6.42M
344.09%5.22M
-51.20%1.18M
--2.41M
Total other finance cost
129.60%636K
--277K
----
----
----
Other net income (expense)
-1,076.64%-30.14M
-86.90%3.09M
695.98%23.55M
-74.14%2.96M
11.44M
Special income (charges)
---804K
----
----
----
----
-Less:Impairment of capital assets
--804K
----
----
----
----
Other non- operating income (expenses)
-1,050.58%-29.34M
-86.90%3.09M
695.98%23.55M
-74.14%2.96M
--11.44M
Income before tax
103.13%3.09M
-22.57%-98.62M
-67.86%-80.47M
-54.02%-47.94M
-31.12M
Income tax
-138.92%-2.12M
12,026.67%5.46M
101.48%45K
6.36%-3.05M
-3.26M
Net income
105.01%5.21M
-29.27%-104.08M
-79.36%-80.51M
-61.08%-44.89M
-27.87M
Net income continuous Operations
105.01%5.21M
-29.27%-104.08M
-79.36%-80.51M
-61.08%-44.89M
---27.87M
Minority interest income
Net income attributable to the parent company
105.01%5.21M
-29.27%-104.08M
-79.36%-80.51M
-61.08%-44.89M
-27.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
105.01%5.21M
-29.27%-104.08M
-79.36%-80.51M
-61.08%-44.89M
-27.87M
Basic earnings per share
104.81%0.0161
-17.54%-0.335
-63.32%-0.285
-46.15%-0.1745
-0.1194
Diluted earnings per share
104.81%0.0161
-17.54%-0.335
-63.32%-0.285
-46.15%-0.1745
-0.1194
Dividend per share
Currency Unit
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021(FY)Dec 30, 2020(FY)Dec 30, 2019
Total revenue 218.40%496.66M3,084.65%155.98M4.66%4.9M34.29%4.68M3.49M
Operating revenue 218.40%496.66M3,084.65%155.98M4.66%4.9M34.29%4.68M--3.49M
Cost of revenue 205.67%188.16M2,315.86%61.56M25.89%2.55M-20.41%2.02M2.54M
Gross profit 226.71%308.5M3,918.21%94.43M-11.52%2.35M181.95%2.66M942K
Operating expense 42.13%269.27M87.29%189.44M92.88%101.15M27.29%52.44M41.2M
Selling and administrative expenses 43.15%133.85M129.12%93.5M112.46%40.81M65.77%19.21M--11.59M
-Selling and marketing expense 238.96%54.87M174.78%16.19M390.10%5.89M285.26%1.2M--312K
-General and administrative expense 2.16%78.99M121.42%77.32M93.93%34.92M59.70%18.01M--11.28M
Research and development costs 122.69%128.84M69.49%57.86M47.87%34.14M9.09%23.09M--21.16M
Depreciation amortization depletion 25.36%6.74M3.96%5.38M5.98%5.17M15.25%4.88M--4.24M
-Depreciation and amortization 25.36%6.74M3.96%5.38M5.98%5.17M15.25%4.88M--4.24M
Other operating expenses -100.53%-173K55.50%32.7M299.30%21.03M25.02%5.27M--4.21M
Operating profit 141.29%39.24M3.83%-95.02M-98.45%-98.8M-23.67%-49.79M-40.26M
Net non-operating interest income expense -90.57%-12.75M-28.25%-6.69M-370.94%-5.22M52.03%-1.11M-2.31M
Non-operating interest income 101,800.00%1.02M--1K-----31.63%67K--98K
Non-operating interest expense 104.74%13.14M22.96%6.42M344.09%5.22M-51.20%1.18M--2.41M
Total other finance cost 129.60%636K--277K------------
Other net income (expense) -1,076.64%-30.14M-86.90%3.09M695.98%23.55M-74.14%2.96M11.44M
Special income (charges) ---804K----------------
-Less:Impairment of capital assets --804K----------------
Other non- operating income (expenses) -1,050.58%-29.34M-86.90%3.09M695.98%23.55M-74.14%2.96M--11.44M
Income before tax 103.13%3.09M-22.57%-98.62M-67.86%-80.47M-54.02%-47.94M-31.12M
Income tax -138.92%-2.12M12,026.67%5.46M101.48%45K6.36%-3.05M-3.26M
Net income 105.01%5.21M-29.27%-104.08M-79.36%-80.51M-61.08%-44.89M-27.87M
Net income continuous Operations 105.01%5.21M-29.27%-104.08M-79.36%-80.51M-61.08%-44.89M---27.87M
Minority interest income
Net income attributable to the parent company 105.01%5.21M-29.27%-104.08M-79.36%-80.51M-61.08%-44.89M-27.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 105.01%5.21M-29.27%-104.08M-79.36%-80.51M-61.08%-44.89M-27.87M
Basic earnings per share 104.81%0.0161-17.54%-0.335-63.32%-0.285-46.15%-0.1745-0.1194
Diluted earnings per share 104.81%0.0161-17.54%-0.335-63.32%-0.285-46.15%-0.1745-0.1194
Dividend per share
Currency Unit AUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data